Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Adriaan Moelker
Michael Schneiders
Board:
Michael Majerus
Anna Carina Eichhorn
Florian Schnabel
Ursula La Cognata
Christine Uekert
Stephen Catling
Shareholding in %:
Daniel Hopp 5.6
Deka Investment GmbH 1.89
FPM Frankfurt Performance Management AG 1.65
Generali Investments LLC 0.17
KBC Asset Management NV 0.27
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH 1.51
Martin Putsch 31.5
Pbg Zweite GmbH 15.1
SMS & Cie. Vermögensmanagement GmbH 0.09
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.99
Freefloat 39.24
Address: Darmstädter Strasse 34-36, 64673 Zwingenberg
T: +49-6251-9331-0
F: +
I: http://www.brain-biotech.de
E: public@brain-biotech.de